Royalty Pharma delivered robust FY25 results, with double-digit growth in Royalty Receipts and Portfolio Receipts. Check out ...
Berkshire Hathaway benefits from a surge in Japanese equities, with its Japan positions now estimated at $40B market value.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results